GSK, Vir enter Phase 3 clinical trials for Covid-19 drug VIR-7831
The phase 3 COMET-ICE trial will evaluate the safety and efficacy of a single intravenous infusion of VIR-7831…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Oct 20
The phase 3 COMET-ICE trial will evaluate the safety and efficacy of a single intravenous infusion of VIR-7831…
06 Oct 20
Through the acquisition, Bristol Myers will benefit from MyoKardia’s investigational cardiovascular medicine mavacamten for obstructive hypertrophic cardiomyopathy (HCM)…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Oct 20
Aermony RespiClick is packaged in an advanced device to simplify the administration of inhaled therapy and reduce miscalculations…
05 Oct 20
The US regulatory agency granted the breakthrough status for Farxiga based on the positive clinical evidence from the…
05 Oct 20
The FDA approval is based on the Phase 3 CheckMate -743 trial, which evaluated Opdivo plus Yervoy compared…
01 Oct 20
VLP Therapeutics’ Covid-19 vaccine is said to be a self-amplifying RNA vaccine that leverages lipid nanoparticle formulation, a…
01 Oct 20
Simponi Aria is claimed to be the first and only fully human anti-tumour necrosis factor (TNF)-alpha biologic agent…
30 Sep 20
REBLOZYL is claimed to be the only approved erythroid maturation agent for the treatment of anemia in certain…
30 Sep 20
Pfizer also obtains exclusive rights to CStone’s cancer drug sugemalimab in mainland China
29 Sep 20
The FreeStyle Libre 3 System is claimed to feature world’s thinnest and smallest wearable glucose sensor and enables…